Cercar
03/11/2025
Dissecting the heterogeneity of IGHV-mutated CLL: An eric study
Chatzikonstantinou, T, Agathangelidis, A, Talimtzi, P, Laidou, S, Minga, E, Roussos, A, Angelopoulou, M, De Tomas, MA, Antic, D, Baran-Marszak, F, Bödör, C, Albareda, FB, Catherwood, M, Chatzileontiadou, S, Chessa, C, Coscia, M, Crespo, M, Cuneo, A, Davis, Z, Dimou, M, Doubek, M, Efstathopoulou, M, Espinet, B, Gaidano, G, Gupta, R, Hatzimichael, E, Herishanu, Y, Karamanli, T, Konstantinou, E, Kotsianidis, I, Koumpis, AE, Laszlo, T, Levy, V, Machairas, A, Martini, F, Moia, R, Mouhssine, S, Prat, AM, Murru, R, Mpalaoura, E, Pangalis, G, Papaioannou, M, Pavlova, S, Plevova, K, Pospisilova, S, Puiggros, A, Rani, L, Rigolin, GM, Romano, I, Rossi, D, Serna, A, Simkovic, M, Smolej, L, Stavrogianni, N, Vujovic, KT, Trentin, L, Vassilakopoulos, T, Visentin, A, Vitale, C, Vrachiolias, G, Scarfo, L, Chatzidimitriou, A, Ghia, P, Stamatopoulos, K. Dissecting the heterogeneity of IGHV-mutated CLL: An eric study. BLOOD. 2025; 146DOI:10.1182/blood-2025-2120. PMID:. IF:23.100(Q1/1D).
03/11/2025
Central nervous system involvement in Mantle Cell Lymphoma: A retrospective multicenter cohort study from the spanish geltamo group
Bastos-Oreiro, M, Cabirta, A, Perez, A, Carreres, AS, De Villambrosia, SG, Canelo, M, Moya, AMGN, Benito, BD, Gutiérrez, PV, Vicente, FD, Caballero, JC, Jiménez-Ubieto, A, Belmonte, DG, Prat, AM, Barca, EG, Henríquez, HDL, Herranz, ER, Garcia-Sancho, AM, Grande, C, Nicolás, C, Gutierrez, A, Gomez-Llobell, M, Rivas, JAH, Sánchez-González, B, Campos, AF, Trillo, RA, Donato, E, Cozzarell, SRV, Ordoñez, SS, De La Mano, EP, Prieto, PG, Avaria, A, Blanco, LV, Roldán-Pérez, A, Cordoba, R, Sancho, JM, Gine, E, Garces, VN, Abrisqueta, P, Niebla, AM. Central nervous system involvement in Mantle Cell Lymphoma: A retrospective multicenter cohort study from the spanish geltamo group. BLOOD. 2025; 146DOI:10.1182/blood-2025-3585. PMID:. IF:23.100(Q1/1D).
03/11/2025
Incidence and molecular underpinnings of donor-cell derived neoplasm among spanish transplantation centers
Gabarros-Subira, M, Torres-Esquius, S, Pomares, H, Beas, F, Suárez-Gonzalez, J, Sanchez, AH, Lopez-Fernandez, E, López, GR, Hermosin-Ramos, M, Carreño, G, Castillo, IM, García, JD, Santiago, M, Pascual, M, Díaz-Beyá, M, Carrascosa, GB, Montoya, RT, Ortuño, FJ, Vives, S, Mañó, LG, Casares, MTG, Alfonso-Pierola, A, Pris-Vilaespesa, M, Revilla, N, Alonso, S, Iborra, A, Lores, BF, Díaz, RMA, Cervera, J, Corral, LL, Canela, MP, Buño, I, Montoro, MJ, Hernandez, F, Albareda, FB, Arnan, M, Valcarcel, D, Martinez-Laperche, C, Jerez, A. Incidence and molecular underpinnings of donor-cell derived neoplasm among spanish transplantation centers. BLOOD. 2025; 146DOI:10.1182/blood-2025-4275. PMID:. IF:23.100(Q1/1D).
01/09/2025
Rapcabtagene Autoleucel (YTB323) Phase 2 Trial in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL): Clinical
Riedell, PA, Kwon, M, Flinn, IW, Dickinson, MJ, Solano, C, Jaeger, U, Briones, J, Kato, K, Fleming, S, Bachy, E, Rambaldi, A, Shune, LO, Shah, NN, Blaise, D, Frigault, MJ, Ramakrishnan, A, Yang, A, Pearson, D, Zia, A, Segura, E, Masood, A, Barba, P. Rapcabtagene Autoleucel (YTB323) Phase 2 Trial in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL): Clinical. Clinical Lymphoma Myeloma & Leukemia. 2025; 25DOI:. PMID:. IF:2.700(Q2/4D).